您的位置: 首页 > 农业专利 > 详情页

FOXC1 ANTIBODIES AND METHODS OF THEIR USE
专利权人:
JOHN WAYNE CANCER INSTITUTE
发明人:
Xiaojiang CUI
申请号:
US16285772
公开号:
US20200025764A1
申请日:
2019.02.26
申请国别(地区):
US
年份:
2020
代理人:
摘要:
In one embodiment, an isolated antibody or functional fragment thereof which binds an antigenic peptide sequence of human FOXC1 is provided herein. Such antibodies or functional fragments may be used to diagnose, prognose or treat basal-like breast cancer. The antibody or functional fragment may be a monoclonal antibody produced by a hybridoma cell line. Thus, a hybridoma cell line that produces a FOXC1 monoclonal antibody which binds an antigenic peptide sequence of human FOXC1 as described above is also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充